Shares of Tristel plc (LON:TSTL - Get Free Report) hit a new 52-week low during trading on Wednesday . The company traded as low as GBX 346 ($4.52) and last traded at GBX 362 ($4.73), with a volume of 209155 shares trading hands. The stock had previously closed at GBX 357.50 ($4.67).
Tristel Stock Up 1.3 %
The business's 50-day moving average is GBX 432.35 and its two-hundred day moving average is GBX 446.82. The firm has a market capitalization of £172.49 million, a price-to-earnings ratio of 2,750.00 and a beta of 0.23. The company has a debt-to-equity ratio of 19.12, a quick ratio of 3.83 and a current ratio of 4.92.
Insiders Place Their Bets
In other Tristel news, insider Elizabeth Dixon sold 50,000 shares of Tristel stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of GBX 397 ($5.18), for a total transaction of £198,500 ($259,206.06). Company insiders own 4.89% of the company's stock.
About Tristel
(
Get Free Report)
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tristel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tristel wasn't on the list.
While Tristel currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
